Home » Newsletters » BioWorld MedTech

BioWorld MedTech

June 23, 2010

View Archived Issues

FDA to accept PMA filing for ev3's embolization device

Report from Europe: Skyline licenses TrovaGene's NMP1 technology for product

Washington roundup: HHS offers $250 million for prevention despite iffy data

Court report: Spectranetics to pay $8.5M to settle upcoming litigation

MDD's food for med-tech thought

MDD/BioWorld win SIPA awards for book, series

Financings roundup: Covidien prices offering for its ev3 acquisition

Agreements/contracts: Mayo Clinic, U. of Illinois compose research alliance

New ventures: BTT says new technology will 'transform' temp measurement

Grants roundup: Apollo Endosurgery gets $5M for new GI cancer applications

Product Briefs

People in the News

MDD's Oncology Extra

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld Science
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...